Artificial intelligence continues to reshape healthcare delivery, particularly in diagnostics, imaging, and care coordination. For established healthcare platforms seeking to integrate innovative capabilities, effective transactions are not always single-step acquisitions. Phased relationships, beginning with commercial alignment and structured with the
Sidley Austin LLP
Sidley Austin LLP is a global law firm that publishes detailed legal analysis and commentary primarily focused on corporate governance, securities litigation, regulatory compliance, and related litigation matters. Its blog content often covers court decisions, regulatory developments, and best practices affecting corporate charters, bylaws, and compliance risks. The firm provides insights into jurisdictional issues, whistleblower implications, and evolving regulatory frameworks impacting financial institutions, pharmaceutical pricing, and digital regulations. Sidley Austin's publications serve legal professionals and corporate clients seeking updates and expert perspectives on complex legal and regulatory challenges.
Website:
https://sidley.com
Latest from Sidley Austin LLP - Page 6
OSHA Schedules Public Hearings on Deregulatory Proposals
The Occupational Safety and Health Administration (OSHA) has scheduled several informal public hearings on more than 20 deregulatory rulemaking proposals that OSHA released last summer, along with a recent proposal addressing compliance deadlines under OSHA’s Walking-Working Surfaces standard. Together, these…
The EU AI Act’s Machinery Exemption: Does It Extend to Surgical Robotics?
The EU’s latest AI reforms are intended to reduce regulatory duplication for products already subject to extensive sector-specific regulation. For manufacturers of surgical robotics, however, they leave unresolved how AI embedded within increasingly sophisticated surgical systems will be regulated in…
Delaware Supreme Court Affirms Limits on Hypothetical Bylaw Challenges
On April 29, 2026, the Delaware Supreme Court affirmed the Court of Chancery’s dismissal of consolidated challenges to advance notice bylaws adopted in 2023 by each of The AES Corporation and Owens Corning (In re The AES Corporation and…
EPA Proposal Could Reduce New Source Review-Related Delays for Major Construction Projects
The U.S. Environmental Protection Agency (EPA) recently proposed a rule that could allow project developers of data centers, energy projects, and other facilities to begin certain site-development and infrastructure activities before obtaining a Clean Air Act (CAA) New Source Review…
Sidley Highly Ranked in Securities Litigation by Chambers USA 2026
We’re honored to share that Sidley’s Securities and Shareholder Litigation team has been recognized in Chambers USA 2026, earning five practice area rankings and more than 20 lawyer rankings across Sidley’s national platform.The post Sidley Highly Ranked in Securities Litigation…
Cyber Strategy at the AI Frontier: President Trump Releases Executive Order to Promote Advanced Artificial Intelligence Innovation and Security
On June 2, 2026, President Trump issued the Executive Order, Promoting Advanced Artificial Intelligence Innovation and Security. The Executive Order carries forward several priorities included in President Trump’s Cyber Strategy for America, released in March 2026.[1] The Executive Order…
Risk Analysis in the Crosshairs: Four Recent Ransomware Resolutions Preview the HIPAA Security Rule Amendments
On April 23, 2026, the U.S. Department of Health and Human Services’ (HHS) Office for Civil Rights (OCR) announced resolution agreements and corrective action plans with four regulated entities following separate ransomware investigations under the Health Insurance Portability and Accountability…
The BUILD America 250 Act: Creating a Federal Framework for Autonomous Commercial Vehicles
On May 22, the House Transportation and Infrastructure Committee approved the BUILD America 250 Act, a five-year surface transportation reauthorization bill intended to replace the Infrastructure Investment and Jobs Act (IIJA), which expires on September 30, 2026. In addition…
Most-Favored-Nations Drug Pricing Policy: White House Quietly Releases Report Describing Voluntary MFN Deals
On May 6, 2026, the White House Council of Economic Advisors (CEA)[1] discretely released the first report quantifying its view of the projected savings generated by the administration’s Most-Favored-Nation (MFN) drug pricing policy framework, based on existing MFN pricing agreements…